Determination of degradation products of sumatriptan succinate using LC-MS and LC-MS-MS
- 30 July 2001
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 26 (3) , 367-377
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometryRapid Communications in Mass Spectrometry, 2000
- Stability of sumatriptan succinate in polypropylene syringesAmerican Journal of Health-System Pharmacy, 1999
- Stability of sumatriptan succinate in extemporaneously prepared oral liquids.American Journal of Health-System Pharmacy, 1997
- A method using a liquid chromatographic-electrospray-mass spectrometric assay for the determination of antimigraine compounds: preliminary pharmacokinetics of MDL 74,721, sumatriptan and naratriptan, in rabbitJournal of Pharmaceutical and Biomedical Analysis, 1997
- SEROTONIN 1D (5-HT1D) AGONISTS AND OTHER AGENTS IN ACUTE MIGRAINENeurologic Clinics, 1997
- Determination of sumatriptan succinate in human plasma by high-performance liquid chromatography with coulometric detection and utilization of solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Fully automated assay for the determination of sumatriptan in human serum using solid-phase extraction and high-performance liquid chromatography with electrochemical detectionJournal of Pharmaceutical and Biomedical Analysis, 1996
- SumatriptanDrugs, 1994
- SumatriptanThe Lancet, 1993
- Development and validation of a liquid chromatographic-mass spectrometric assay for the determination of sumatriptan in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1989